AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2502890
Drug: Antithymocyte globulin
RxNorm normalized name: Rabbit antithymocyte globulin
DrugBank: Antithymocyte immunoglobulin (rabbit) (DB00098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithymocyte globulin (ATG) therapy, 5 doses every other day, 60-min intravenous infusion
Trial: 2502890
Drug: Antithymocyte globulin
RxNorm normalized name: Rabbit antithymocyte globulin
DrugBank: Antithymocyte immunoglobulin (rabbit) (DB00098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithymocyte globulin (ATG) therapy
Trial: 12221048
Drug: Full-dose almonds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose almonds (73±3 g/d)
Trial: 18555827
Drug: Half-dose almonds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half-dose almonds
Trial: 10878510
Drug: Phenoxymethylpenicillin (40‐60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenoxymethylpenicillin (40‐60 mg/kg/day) for 10 days (n = 28)
Trial: 10878510
Drug: Amoxicillin‐clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanic acid (20‐40 mg/kg/day) for 10 days (n = 23)
Trial: 7793184
Drug: Midazolam (0.13
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.13 mg.kg‐1)
Trial: 7793184
Drug: Thiopental (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (4 mg.kg‐1)
Trial: 7793184
Drug: Midazolam (0.13
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.13 mg.kg‐1) combined with Flumazenil (6 micrograms.kg‐1)
Trial: 7004999
Drug: Motilin infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Motilin infusion of 0.2 pmol/kg/min
Trial: 6143184
Drug: Relaxation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation therapy alone (group A)
Trial: 25917895
Drug: Probiotic treatment
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic treatment with Saccharomyces boulardii (n = 15)
Trial: 25917895
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (n = 18)
Trial: 16030100
Drug: Twice-weekly weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-weekly weight training (0 to 12 months)
Trial: 16030100
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment group (no exercise for 6 months, then training for 6 months)
Trial: 10521838
Drug: Direct preparations
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct preparations and cultured cells
Trial: 2074162
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (Nxs) 550 mg twice each day by mouth
Trial: 7018862
Drug: Cimetidine (dosage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine (dosage not specified)
Trial: 7018862
Drug: Antacid (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid (specific type not mentioned)
Trial: 30606161
Drug: Text messages
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Text messages about the availability of oral HIV self-test kits sent three times to the intervention group.
Trial: 26355952
Drug: Hydrolyzed water‐soluble
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrolyzed water‐soluble egg membrane (WSEM), 450 mg daily
Trial: 20027498
Drug: Recombinant Hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant Hepatitis B vaccine (VrHB‐IB)
Trial: 20027498
Drug: Recombinant Hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant Hepatitis B vaccine (VrHB‐IB) with increased antigen concentration to 25 microg
Trial: 20027498
Drug: Control (reference
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (reference vaccine)
Trial: 12782208
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg aspartame
Trial: 12782208
Drug: 176 mg
RxNorm normalized name: salicylic acid 176 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 176 mg aspartic acid + 224 mg phenylalanine
Trial: 12782208
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg corn flour (control)
Trial: 7676242
Drug: Amoxicillin plus
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin plus gentamicin
Trial: 9315991
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg quazepam
Trial: 22030088
Drug: 200-mg twice
RxNorm normalized name: BCG, live, Tice strain 50 MG/ML [Tice BCG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-mg twice daily celecoxib
Trial: 22030088
Drug: 400-mg twice
RxNorm normalized name: BCG, live, Tice strain 50 MG/ML [Tice BCG]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-mg twice daily celecoxib
Trial: 22030088
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of 200-mg twice daily celecoxib
Trial: 22030088
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of 400-mg twice daily celecoxib
Trial: 22030088
Drug: Concurrent use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent use of low-dose aspirin
Trial: 17884846
Drug: Transport with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transport with tirofiban (10 microg/kg bolus i.v. + i.v. infusion 0.1 microg/kg/min) for primary PCI
Trial: 12744577
Drug: Real ECT
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real ECT treatment
Trial: 12744577
Drug: Simulated ECT
RxNorm normalized name: bisacodyl
DrugBank: Bisacodyl (DB09020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simulated ECT treatment (Control)
Trial: 30796112
Drug: Pump Suspension
RxNorm normalized name: INTESTINAL PUMP SUSPENSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pump Suspension (PS) at exercise onset
Trial: 28434463
Drug: Prenatal yoga
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal yoga (20-week intervention with two weekly 70-min yoga sessions led by a certified midwife)
Trial: 24113059
Drug: Topical formalin
RxNorm normalized name: formalin
DrugBank: Formaldehyde (DB03843)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical formalin
Trial: 21982170
Drug: Halothane anesthesia
RxNorm normalized name: Halothane
DrugBank: Halothane (DB01159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halothane anesthesia with oral midazolam premedication (0.5mg/kg 20‐30 minutes before induction)
Trial: 21982170
Drug: Sevoflurane anesthesia
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane anesthesia with oral midazolam premedication
Trial: 17678651
Drug: Vaginal estradiol
RxNorm normalized name: estradiol Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estradiol supplementation (E(2) 2 mg twice a day starting on the day of ET)
Trial: 17678651
Drug: Vaginal estradiol
RxNorm normalized name: estradiol Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estradiol supplementation (E(2) 2 mg twice a day starting on the day of ET) in long GnRH agonist suppression protocol
Trial: 17678651
Drug: No E(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No E(2) supplementation (control group) in long GnRH agonist suppression protocol
Trial: 17678651
Drug: Vaginal estradiol
RxNorm normalized name: estradiol Vaginal Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal estradiol supplementation (E(2) 2 mg twice a day starting on the day of ET) in GnRH antagonist or microdose GnRH agonist protocols
Trial: 17678651
Drug: No E(2)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No E(2) supplementation (control group) in GnRH antagonist or microdose GnRH agonist protocols
Trial: 16533095
Drug: 8-week, one-on-one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-week, one-on-one book-sharing intervention with twice-weekly 15-min sessions
Trial: 14700441
Drug: 1% topical
RxNorm normalized name: SSD 1% Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% topical pimecrolimus cream
Trial: 27389963
Drug: Basic periodontal
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic periodontal therapy + 0.12% chlorhexidine
Trial: 27389963
Drug: Basic periodontal
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic periodontal therapy + placebo
Trial: 23040413
Drug: L-arginine-enriched biscuits
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine-enriched biscuits
Trial: 23040413
Drug: Powdered L-arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Powdered L-arginine
Trial: 21569473
Drug: 4 l/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 l/min of oxygen from a simple face mask
Trial: 21569473
Drug: 4 l/min
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 l/min air from a face mask
Trial: 16957557
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg once/day
Trial: 16957557
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg once/day
Trial: 11110735
Drug: Candesartan 16
RxNorm normalized name: candesartan 16 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan 16 mg once daily
Trial: 11110735
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (Candesartan + Lisinopril)
Trial: 9066184
Drug: Oxatomide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxatomide (1 to 2 mg/kg body weight, twice daily)
Trial: 3089465
Drug: Adenosine (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine (maximum tolerable dose ranging from 10.6 to 37.1 mg)
Trial: 12357162
Drug: Aminophylline 5
RxNorm normalized name: aminophylline 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline 5 mg/kg
Trial: 3089465
Drug: Dipyridamole 10
RxNorm normalized name: dipyridamole 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole 10 mg
Trial: 22870960
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with 5.1J (60J/cm²) energy density, applied at three different points intraorally immediately and at 48 and 72 hours post-surgery
Trial: 20046173
Drug: Ketamine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (1.5 mg/kg) and Diazepam (0.1 mg/kg)
Trial: 20046173
Drug: Midazolam (0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.05 mg/kg) and Fentanyl (1 microg/kg)
Trial: 16322468
Drug: Total therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total therapy 1 (TT1)
Trial: 18371114
Drug: Total therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total therapy 2 (TT2) without THAL
Trial: 18371114
Drug: Total therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total therapy 2 (TT2)
Trial: 18371114
Drug: Total therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total therapy 2 (TT2) without cytogenetic abnormalities (CA)
Trial: 18371114
Drug: Total therapy
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total therapy 2 (TT2) with cytogenetic abnormalities (CA)
Trial: 8227859
Drug: Terfenadine (antihistamine)
RxNorm normalized name: terfenadine Oral Tablet [Antihistamine Forte]
DrugBank: Terfenadine (DB00342)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terfenadine (antihistamine)
Trial: 30370830
Drug: Daily oral
RxNorm normalized name: GEMTESA 75 MG Once-Daily Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily oral and vaginal tenofovir formulations for HIV prevention
Trial: 18327092
Drug: 'in‐treatment' segmental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 'in‐treatment' segmental wall motion abnormalities
Trial: 15796632
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment (DTC)
Trial: 1908604
Drug: Almitrine 100
RxNorm normalized name: almitrine
DrugBank: Almitrine (DB01430)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Almitrine 100 mg twice a day reducing to 50 mg twice a day over 48 hours
Trial: 6150839
Drug: Bisoprolol 5
RxNorm normalized name: bisoprolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol 5 mg and 10 mg doses per 24 hours
Trial: 26415520
Drug: Self-efficacy enhancement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-efficacy enhancement program (three individualized in-hospital education sessions and three weekly sessions of telephone counseling)
Trial: 26415520
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (supervised exercise and activities of daily living performance regimen, education)
Trial: 16137275
Drug: Daily multidisciplinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multidisciplinary geriatric intervention (n=155)
Trial: 12177585
Drug: Haloperidol (3-15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (3-15 mg/day)
Trial: 20008235
Drug: Non-ASCT strategies
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ASCT strategies (salvage radiotherapy or non-ASCT chemotherapy)
Trial: 17464688
Drug: Computerized cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computerized cognitive behavioural therapy (CCBT)
Trial: 15675207
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml 1% lignocaine pre‐treatment followed by propofol and 2 ml saline
Trial: 15675207
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml saline followed by propofol and 2 ml 2% lignocaine
Trial: 11704028
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin and mineral supplements
Trial: 2853459
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (5,000 units every 8 hours)
Trial: 30516625
Drug: Tranexamic Acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic Acid (TXA) 50 mg/kg loading dose and 10 mg/kg/h infusion
Trial: 25609939
Drug: Concurrent medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent medications considered strong or moderate inhibitors of CYP2D6
Trial: 25609939
Drug: Concurrent medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent medications considered strong or moderate inhibitors of CYP3A4/5
Trial: 20873909
Drug: CCAL (computer-assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCAL (computer-assisted cognitive behavioral therapy)
Trial: 20873909
Drug: ICBT (individual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICBT (individual cognitive behavioral therapy)
Trial: 16637791
Drug: Electronic tool
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic tool for metformin monitoring
Trial: 8646249
Drug: Triglyceride-heparin infusion
RxNorm normalized name: CAPRYLIC TRIGLYCERIDE
DrugBank: Tricaprylin (DB12176)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triglyceride-heparin infusion
Trial: 29274034
Drug: Bovine colostrum
RxNorm normalized name: Bovine Colostrum
DrugBank: Bos taurus colostrum (DB19249)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine colostrum (COL) 20 g/day
Trial: 19437334
Drug: Aspirin 160
RxNorm normalized name: aspirin 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 160 mg per day for 7‐10 days
Trial: 18640465
Drug: Pitavastatin 2
RxNorm normalized name: PITAVASTATIN 2MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 2 mg/d
Trial: 10409530
Drug: sotalol 80
RxNorm normalized name: sotalol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sotalol 80 mg twice daily
Trial: 7650808
Drug: Paternal white
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paternal white blood cell immunization (published studies, random treatment effect model)
Trial: 7650808
Drug: Paternal white
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paternal white blood cell immunization (individual patient data, random treatment effect model)
Trial: 7650808
Drug: Paternal white
RxNorm normalized name: White Petrolatum
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paternal white blood cell immunization (unpublished trials, random treatment effect model)
Trial: 1692988
Drug: Galanin (Gal)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galanin (Gal) plus growth hormone‐releasing hormone (GHRH)
Trial: 7417900
Drug: Topical antibiotic
RxNorm normalized name: Tetracycline and derivatives, topical antibiotics
DrugBank: Polymyxin B (DB00781)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical antibiotic spray (neomycin sulfate, polymyxin B sulfate, zinc bacitracin)
Trial: 22930789
Drug: Atomoxetine (target
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (target dose: 1.2 mg/kg per day)
Trial: 17531918
Drug: Inotropic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inotropic drugs
Trial: 2672774
Drug: Sucrose (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sucrose (45 g, 9% of total daily energy) added to diet
Trial: 2672774
Drug: Aspartame (162
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartame (162 mg) added to diet
Trial: 31630479
Drug: Apixaban 10
RxNorm normalized name: Apixaban
DrugBank: Apixaban (DB06605)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Apixaban 10 mg twice daily for seven days followed by 5 mg twice daily for six months
Trial: 31630479
Drug: Dalteparin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (200 IU/kg for one month followed by 150 IU/kg once daily)
Trial: 25697717
Drug: 5-mm injection
RxNorm normalized name: glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-mm injection depth of insulin lispro (0.25 U/kg)
Trial: 25697717
Drug: 8-mm injection
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 8-mm injection depth of insulin lispro (0.25 U/kg)
Trial: 23978642
Drug: Low-dose salbutamol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose salbutamol (1μg)
Trial: 9138658
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran fiber (2.0 or 13.5 g/day)
Trial: 9138658
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (250 or 1500 mg/day)
Trial: 9138658
Drug: Placebo (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2.0 g of wheat bran fiber plus 250 mg of calcium carbonate during 3-month run-in)
Trial: 1381022
Drug: Metoprolol 50
RxNorm normalized name: metoprolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 50 mg b.i.d.
Trial: 29154553
Drug: Gender‐neutral Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gender‐neutral Cognitive Behavioral Therapy (GN‐CBT)
Trial: 25886088
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream combined with salicylic acid 15%
Trial: 2741976
Drug: Propranolol (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (80 mg, four times daily)
Trial: 2741976
Drug: Nifedipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20 mg, four times daily)
Trial: 16931609
Drug: Glutamine-enriched enteral
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine-enriched enteral nutrition (0.3 g/kg/d)
Trial: 15451912
Drug: Fasting insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fasting insulin levels, BMI, waist-to-hip ratio
Trial: 15451912
Drug: Two-hour postload
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-hour postload plasma glucose (2-h PG), serum insulin, fasting plasma glucose
Trial: 15451912
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of systolic and diastolic blood pressure
Trial: 15451912
Drug: Urinary albumin
RxNorm normalized name: Albumin Aggregated
DrugBank: Albumin Aggregated (DB14230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urinary albumin excretion rate
Trial: 9255764
Drug: Skinner herpes
RxNorm normalized name: herpesvirus 2, human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skinner herpes simplex vaccine (NFU.Ac.HSV‐1(S‐)MRC) administered at 0, 1, and 2 months